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Pathogenesis of Human Urinary
Bladder Cancer
by George T. Bryan*
The pathogenesis of bladder cancer is being analyzed at several levels of biological organization,
i.e., population groups, individual whole animal, tissue, cell, molecule, etc. Each of these levels pro-
vides opportunities for mechanistic studies. Yet the integration of these several levels into a cohe-
sive fabric is incomplete. From a clinical point of view, the following seem of importance to human
bladder cancer pathogenesis. The initiation, promotion, and progression of bladder cancer involves
several factors acting concurrently or sequentially. These factors appear to be naturally occurring
or synthetically created chemicals present in the external environment. Human exposures to these
agents may begin in utero, and varying, dynamic qualitative and quantitative exposure patterns
continue through developmental and adult life. Apparent latent periods of development of clinical
bladder cancer may be as short as one, or as long as 50 years or more. Individuals may exhibit dif-
ferential susceptibility to vesical carcinogens, perhaps through phenotypic differences in quantita-
tive biotransformation routes. Differences in bladder epithelial cell susceptibilities probably also
occur, as well as varying local tissue and generalized resistance to neoplasia formation. Older indi-
viduals do not appear to be more resistant to bladder carcinogenesis. A number of animal model
systems have been developed for the study of the in vivo, cellular, and molecular pathogenesis of
bladder cancer. These models replicate many of the known salient features of human bladder can-
cer. Through use of appropriate whole animal models in conjunction with investigations of human
and animal bladder cells and tissues in culture, controlled mechanistic and quantitative studies of
bladder cancer pathogenesis should rapidly develop.
Introduction
The pathogenesis of human bladder cancer has
been investigated intensively for several decades.
Early studies involved descriptions of the develop-
ment of these neoplasms in workers exposed to oc-
cupational arylamines. Latter studies have utilized
animal models, and have been extended to tissue,
cellular, and molecular investigations. Each of these
levels of activity has provided opportunities for
mechanistic studies. Yet we still do not have com-
plete analyses of the processes involved in bladder
carcinogenesis. In order to devise more rational ap-
proaches to the control of this disease, additional
studies are urgently required. The purposes of this
brief review are to integrate the available informa-
tion concerning human bladder cancer pathogenesis
and to direct attention to areas of further investiga-
tion.
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Historical Considerations
Bladder cancer in most humans appears to be
multifactorial in origin and multistage in evolution
(1-8). Our natural environment may contain a
number of factors important in the etiology of blad-
der cancer (5, 6, 9). These factors may have been
present on this planet for as long as humans have.
For example, bracken fern (BF) (Pteridium aquii-
num), now known to be a potent plant experimental
bladder carcinogen, was used by several tribes of
Pacific Northwestern Indians as a dietary staple as
long ago as 14,000 B.C. (10). It continues to be used
as a human food and veterinary feed in many parts
of the world (10, 11). Schistosomiasis, caused by a
parasitic organism, Schistosoma haematobium, was
connected by early Egyptians about 3,000 B.C. to
bladder cancer (11). In Egypt and other areas of
Africa many individuals from an early age develop
repeated infestations by this parasite. Cancer of the
urinary bladder is the most common form of cancer
in Egypt. It was again suggested in 1911 by
Ferguson (12) that schistosomiasis was associated
with bladder cancer. The role of this parasite, if any,
in the etiology of bladder cancer is not clear, al-
though recent data from certain animal studiesseem to support an etiologic relationship (13). Tobac-
co was used for many centuries in tribal ceremonies
by North American Indians. The tobacco smoking
culture was introduced into Europe in 1519 by
Spanish explorers, and its use spread rapidly to
Asia and Africa (8). As early as 1761, Dr. John Hill
reported a relationship between tobacco use and
cancer (8). However, it remained until the 1950s for
the presentation of evidence that cigarette smoking
was etiologic for human bladder cancer (8). To date,
the constituents in tobacco smoke responsible for
bladder carcinogenesis are unknown. Thus the deli-
berate or accidental human exposures to agents in
our natural environment are believed to pose blad-
der carcinogenic hazards.
The urinary bladder was among the first visceral
organs for which specific chemicals were identified
as causal agents of human cancer (14). In 1895 the
German clinician Rehn (15) suggested that workers
employed in the dye industry were at increased risk
of bladder cancer. This report was followed over the
next 50 years by many reports of other workers in
several countries who identified similar clusterings
of industrial exposures to aromatic amines and the
development of bladder cancer in exposed individ-
uals (16). A major and significant epidemiologic
study reported in 1954 by Case and his associates
(17) demonstrated that dye workers were at a 10- to
80-fold increased risk of dying from bladder cancer.
The magnitude of risk varied with the particular
aromatic amine handled, and with the duration and
intensity of exposures. In selected circumstances, as
many as 100% of exposed workers developed blad-
der cancer (16). Benzidine and 2-naphthylamine were
identified as especially potent human bladder car-
cinogens (16, 17). 1-Naphthylamine was associated
with a low risk, possibly due to contamination with
2-naphthylamine (16,17). In 1955, evidence was pre-
sented by clinical investigators that workers ex-
posed to 4-aminobiphenyl were at increased risk of
bladder cancer formation (18). Thus, by the mid-
1950s, conclusive data were available implicating at
least three industrial arylamines as potent human
bladder carcinogens (2, 6, 8, 11, 16). On the basis of
these data, several industrialized countries took
steps to limit or abolish manufacture of these chemi-
cals (2, 16). At that time it was generally believed
that no more than 1% of human urothelial neo-
plasms were etiologically related to exposures to
one or more of these chemicals (16). Thus, studies by
clinicians concerned about causes of bladder cancer
in their patients provided important leads for other
investigators.
The second major advance in studies of the causa-
tion of bladder cancer came in 1938 when Hueper
and co-workers (19) demonstrated the production of
bladder cancer in dogs administered 2-naphthyl-
amine. This major achievement led to the develop-
ment of methods to investigate in the laboratory
under controlled conditions the carcinogenicity of
known or suspected chemical bladder carcinogens.
It also provided opportunities to investigate the cel-
lular and molecular temporal pathogenesis of blad-
der cancer in an effort to elucidate these phenom-
ena and construct rational approaches to their inhi-
bition or reversal (24). Initial work with experimen-
tal animal systems progressed slowly, as bladder
tumor yields were generally low, latent periods of
generation were lengthy and biological evidences of
invasive, metastatic, or lethal qualities were often
lacking (3). Early studies tended to be descriptive
rather than mechanistic. During the past twenty
years more workers have been attracted to study
the causes of bladder cancer, and as a result, signifi-
cant new data and progress have occurred. Aspects
of this topic have been extensively reviewed
recently (1-4, 6, 11, 16). The term "bladder cancer"
as used in this paper is an inclusive term referring
to tumors of the renal pelvis, ureter, bladder, and
urethra. On the basis of present knowledge, it ap-
pears that tumors at these sites probably have simi-
lar causes.
Epidemiological Studies
Incidence rates for bladder cancer in many coun-
tries are increasing at variable rates. For example,
in the United States these rates per 100,000 popula-
tion during the period 1950-54 were: males, 14.1 and
females, 4.4 (7). By 1970-74 comparable incidence
rates were: males, 23.7, and females, 6.1 (7). Several
recent studies have attempted to quantitate the at-
tributable risk percent of factors associated with hu-
man bladder cancer causation (5, 20, 21) (Table 1).
These studies (5, 20, 21) conclusively demonstrate
that cigarette smoking is significantly responsible
for bladder cancer causation in men, and to a lesser
extent, women, in the areas studied. Exposures to
agents in hazardous occupations are also responsi-
ble for augmented risk of bladder cancer, especially
in men. However, factors for a significant fraction of
bladder cancers, especially in women, are not
known (5, 20, 21). Attributable risk percent varies
with age (5). For example, in men in Massachusetts,
the attributable risk percent of ages 20-59, 60-74,
or 75-89, respectively, are: cigarette smoking, 54,
41, 19; hazardous occupations, 23, 20, 7; and un-
known, 23, 39, 74 (5). These data suggest that new
factors responsible for bladder cancer causation
have entered our environment since 1900 and that
these may be related to smoking or hazardous occu-
pations. In Massachusetts, the hazardous occupa-
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Table 1. Attributable risk per cent of factors associated with human bladder cancer causation.
Massachusetts (USA)a Canadab Englandc
Males Females Males Females Males Females
Cigarette smoking 39 29 56 29 85 27
Hazardous occupations 18 6 35 1
Unknown 43 65 9 70 15 73
aData of Morrison and Cole (5).
bData of Miller (20).
cData of Moolgavkar and Stevens (21).
Table 2. Accepted human bladder carcinogens.a
Experimental bladder
Source Chemical carcinogenb
Occupational 4-Aminobiphenyl Yes (D, M, Rab.)
Auramine No
Benzidine Yes (D)
2-Naphthylamine Yes (D, Mon., H, R)
Medicinal Cyclophosphamide Yes (M, R)
N,N-Bis(2-chloroethyl)-2-naphthylamine No
Phenacetin Yes (R)
Habit-tobacco smoke Unknown No
aCited in the literature (1, 2, 5, 6, 8, 9, 11, 14, 16).
bD = dog; M = mouse; Rab. = rabbit; Mon. = monkey; H = hamster; R = rat.
tions identified were those associated with dyes,
rubber, leather, painting, and other organic chemi-
cals (5).
Presented in Table 2 are the sources of exposure,
chemical names, and species exhibiting bladder car-
cinogenesis to chemicals or substances generally ac-
cepted as human bladder carcinogens. Provided in
Table 3 are available data concerning exposure
sources, latency periods, minimum exposure times
and estimated relative risks for several accepted
human bladder carcinogens. It appears from these
data that prolonged exposure to these agents need
not necessarily precede the expression of clinical
bladder cancer. Does this suggest that brief, intense
exposures to potent bladder carcinogens are suffi-
cient to produce clinical disease? Or do these obser-
vations suggest that bladders of susceptible individ-
uals harbor cells previously initiated or promoted
by other, more ubiquitous bladder trophic agents,
and that the final exposure provides a milieu suffi-
cient for clinical malignancy?
From the standpoint of prevention, it is impor-
tant to ask the following. Does age of initial expo-
sure have any influence on the excess risk of blad-
der cancer development? In one study (24), all of the
excess risk of bladder cancer among men with occu-
pational exposures was confined to those whose ex-
posures began prior to age 25. On the other hand, a
recent study by Ohkawa and associates (25) sug-
gests that Japanese men introduced into benzidine
manufacturing industries had a significantly shorter
latent period of bladder cancer development after
age 40 (14.4 + 6.0 years) than did men who began
working in the same industries prior to age 39 (23.6
+ 9.7 years) (p < 0.01). Several other studies (24) also
indicate that older individuals are more susceptible
than younger ones to cancer induction. At this time
it does not seem reasonable to suggest that only
older workers should be placed in potentially carcin-
ogenic work environments.
Another important issue is duration of exposure.
Several studies from occupational sources and from
patients exposed to antineoplastic alkylating agent
therapy showed that relatively short exposures of
4.5 to 12 months appreciably increased bladder can-
cer risk (Table 3). Host capabilities to biotransform
hazardous procarcinogens to ultimate molecular
species, as well as relative susceptibilities of target
tissues may be important variables in determining
increased susceptibility (8).
Other factors in humans that may predispose to
bladder malignancies include anatomic abnormali-
ties, e.g., extrophy, patent urachus, diverticulum,
etc.; persistent infections, e.g., in young females;
schistosomiasis, etc.; urinary sources of natural car-
cinogens from plant food sources, or abnormal tryp-
tophan metabolism; or pelvic radiation in women (1,
4-6, 9, 11, 14). There are significant geographic in-
ternational variations in bladder cancer incidences
of more than 10-fold in males (26). For example, re-
ported (26) rate variations per 100,000 population
were from 28.7 in Bulwayo, Africa to 2.8 in Maori,
203Table 3. Exposure sources, latency periods, minimum exposure times, and relative risks for accepted etiologic factors
in human bladder carcinogenesis.a
Minimum
Latency period, yr exposure time, Relative
Chemical Exposureb Range Mean mo. risk
4-Aminobiphenyl Occ. 15-35 ?c 4.5 200
Auramine Occ. 9-28 ?c 15 13
Benzidine Occ. 1-45 14.4-23.6 ?c 14
N,N-Bis(2-chloroethyl)- Med. 2.5-10 5.5 ?c ?c
2-naphthylamine
2-Naphthylamine Occ. 5-45 16-18 6-12 80
aCited in the literature (1, 2, 5, 6, 8, 9, 11, 14, 16, 22-25).
bOCc. = occupational; Med. = medicinal.
cData not available.
New Zealand. Individuals migrating from Japan (a
low incidence area) to Hawaii (a high incidence area)
developed incidence patterns of bladder cancer in-
termediate between those native Japanese and U.S
whites (26). These data suggest that environmental
determinants play a major role in bladder cancer
causation in humans.
Suspect Natural Environmental
Bladder Carcinogenic Factors
The plant food delicacy BF was associated by
Pamukcu as a major factor in the genesis of bovine
bladder cancer (27, 28). BF and other botanical rela-
tives grow well in moist, shaded areas or hilly pas-
ture lands in temperate and midtropic zones North
and South of the equator (27, 28). As these ferns are
among the first to develop in the spring, they fre-
quently are ingested by grazing domestic animals.
In the fall, farmers in less well developed countries
harvest BF for use as animal bedding, where it may
also be eaten by animals. BF and related plants are
produced commercially in Japan, Canada and north-
eastern parts of the United States for human diets
as greens or salads (27-29). Milk and dairy products
obtained from cows grazing on BF are also con-
sumed by humans. Thus, some humans are directly
exposed to BF in their diets and indirectly exposed
to BF through products obtained from animals. In
several areas of the world an association of BF in-
gestion has been made with the appearance of uri-
nary bladder tumors in cows and water buffalo (27,
28), esophageal and intestinal tumors in cows (28)
and bladder and intestinal tumors in sheep (27, 28).
The incidence of bladder tumors may vary from one
area to another, but may be as high as 90% (27,28).
Evidence that ingested BF is a primary determi-
nant of bladder cancer in cows stems from several
studies (27, 28). Deliberate, prolonged low-level
2 g/kg body weight) feeding of BF produced bladder
cancers in 20 of 30 cows. A mean period of 550 days
from the start of BF feeding to tumor appearance
was determined. Invasive bladder carcinomas ap-
peared within 2.5 years and the induced vesical neo-
plasms were histologically indistinguishable from
the naturally occurring bladder tumors. Other spe-
cies also exhibit a variety of neoplastic lesions when
fed BF (27, 28). Rats developed vesical carcinoma
and ileal adenoma, adenocarcinoma, and sarcoma;
mice demonstrated urinary bladder and intestinal
carcinoma, pulmonary adenoma and adenocarcino-
ma, and leukemia; guinea pigs had bladder and in-
testinal tumors; and Japanese quail displayed intes-
tinal adenocarcinoma following oral administration
of BF.
A recent epidemiologic study in Japan suggested
that daily intake of BF by humans significantly in-
creased risk of development of esophageal cancer
(29). When combined with a hot tea gruel (chagayu)
drink, the relative esophageal cancer risk was in-
creased in males to 5.2 and in females to 4.7. Addi-
tion of cigarette smoking to daily intake of BF and
chagayu further increased the relative esophageal
cancer risk in men to 9.2 and in women to 6.4. Com-
bined use of BF, chagayu, and cigarettes resulted in
a 34-fold higher relative esophageal cancer risk for
both sexes. Combined attributable risk of these fac-
tors to esophageal cancer development was calcu-
lated as 80.2% It was suggested that BF acted as
an initiator, and the hot tea gruel as a promoter or
localizer of these neoplasms in the human popula-
tions studied. Daily intake of meats and fruits
tended to lower esophageal cancer risk. Human
bladder cancer was not studied (29).
The human hazard from BF is not restricted to
direct consumption because lactating cows fed BF
excreted in their milk a urinary and intestinal tract
carcinogen for rats, and a mutagen for S. typhimu-
rium TA 100 (30). Humans may be exposed to the
BF carcinogen present in milk and dairy products
where grazing cattle ingest BF, especially under
free-range conditions. Infants may be exposed to
the BF carcinogen through maternal milk, if the
mother consumes BF daily. The BF carcinogen can
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pass placental barriers of cows and mice and is ex-
creted in urine of cows and rats fed BF (27, 28).
Fractions of urine obtained from cows fed BF dem-
onstrated carcinogenic activity when implanted in-
travesically in mice (27, 28). Rats fed BF excreted
two different biologically active compounds in urine
431). One chemical was mutagenic for S. typhimu-
rium TA 98 and TA 100 and was identified as quer-
cetin (31). The other isolate was mutagenic for TA
100 but not TA 98, and its identification is in pro-
gress. We recently have reported the intestinal and
bladder carcinogenicity for rats of quercetin (32). It
appears that BF contains other chemicals as well
that are possible bladder carcinogens.
In addition to BF, some other ferns or other
plants may also be vesical carcinogens. For exam-
ple, it was reported (33) recently that in the absence
of BF, chronic ingestion of mugla fern or rock fern
(Cheilanthes sieberi) was a major cause of bladder
neoplasms in cows residing in Queensland. Hirono
and his associates (34) reported the development of
hepatic and vesical tumors in rats fed Russian com-
frey (Symphytum officinal L.), used by humans as a
green vegetable or tonic. Humans of all ages may
consume these plant-derived carcinogens through
direct ingestion in food or drinks, in prepared herb-
al remedies, or through consumption of derived ani-
mal products, e.g., milk, cheese, etc. In some in-
stances plant-derived carcinogens structurally re-
semble synthetic chemical carcinogens; in other
cases unique structures have been characterized;
and in many circumstances responsible plant carcin-
ogens remain to be isolated and identified (28).
The essential amino acid, L-tryptophan, in the
course of its metabolism gives rise to a number of
urinary primary aromatic amine and quinoline me-
tabolites (35,36). These metabolic pathways are reg-
ulated to a great extent by vitamin B6 (pyridoxine)
(35). Several of these urinary metabolites are ex-
creted in elevated quantities in patients with blad-
der cancer, and quantitative alterations of metabo-
lism are related to relative deficiencies of vitamin
B6 (35). Patients with a greater risk of development
of heterotopic recurrent bladder cancer were those
exhibiting abnormal tryptophan metabolism (37).
Several urinary metabolites of L-tryptophan dis-
played bladder oncogenicity (36). Recent studies (38-
41) suggest that L-tryptophan is cocarcinogenic for
the bladder and may promote bladder carcinogene-
sis.
Data from several studies (5, 20) have suggested
an association between coffee drinking and in-
creased bladder cancer risk. However, other studies
have failed to show such an association, and it is not
yet known if effects of chance variation account for
the discrepant results. Studies of the relationship of
coffee drinking and experimental bladder cancer
have not beenreported.
Suspect Synthetic Chemical
Factors
In addition to the synthetic chemicals discussed
above that have been related etiologically to human
bladder carcinogenesis, or those chemicals that are
produced commercially and are close structural ana-
logs of recognized human bladder carcinogens, more
than 50 chemicals have been reported to display
bladder carcinogenicity for experimental animals (1-
4, 6, 8, 9, 11, 16, 23) (Table 4). In some instances, the
evidence supporting bladder carcinogenic effects is
sparse, stemming from a single study. In other
Table 4. Examples of chemicals with some experimental evidence for bladder carcinogenesis.a
Class Exposuresb Representative chemicals
Amine or azo dyes Occ. 3,3'-Dimethoxybenzidine, 3,3'-dichlorobenzidine, o-tolidine, p-cresidine, o-anisidine, o-
User toluidine, o-aminoazotoluene, diacetylaminoazotoluene, p-dimethylaminoazobenzene,
Environ. citrus red No. 2, oil orange SS, ponceau 3R, Sudan I, Sudan II, N-phenyl-2-
naphthylamine, 4-amino-2-nitrophenol, 3,2'-dimethyl-4-aminodiphenyl, 2-methoxy-3-
aminodibenzofuran, N-2-fluorenylacetamide, dimethylazobenzene, 4,4'-methylene-bis(2-
chloroaniline), 2-aminofluorene
Nitrosamines Bact. Inf. N-Methyl-N'-nitrosourea, N,N-dibutylnitrosamine, N-butyl-N-hydroxybutylnitrosamine, N-
Foods butyl-N-(3-carboxypropyl)-nitrosamine, N-methyl-N-dodecylnitrosamine, N-ethyl-N-(4-hy-
Bev. droxybutyl)nitrosamine
Nitroaryl
Miscellaneous
Occ.
Occ.
Med.
Occ.
Med.
4-Nitrobiphenyl, 2-nitronaphthalene, N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide, formic acid
2-[4-(5-nitro-2-furyl)-2-thiazolyl]hydrazide, N-[4-(5-nitro-2-furyl)-2-thiazolyl]acetamide, 2-
amino-4-(5-nitro-2-furyl)thiazole
4-Ethylsulfonylnaphthalene-1-sulfonamide, diethylene glycol, 3-phenyl-5p-dimethylamino-
ethyl-1,2,4-oxadiazole, 4'-hydroxy-2,3'-dimethylazobenzene, 2(N-butyloxycarbonylmethyl-
ene)-thiazolid-4-one, 2-p-methoxybenzenesulfonamido-5-isobutyl-1,3,4-thiadiazole, phen-
acetin, 4-ethoxyphenylurea, saccharin, cyclamate, quercetin
aCited in the literature (1-4, 6, 8, 9, 11, 16, 23).
bocc. = occupational; Environ. = environmental; Bact. Inf. = bacterial infection; Bev. = beverage; Med. = medicinal.
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circumstances the evidence is strong, supported by
multiple studies or consistent observations in sever-
al species. Some of these chemicals, e.g., N-[445-ni-
tro-2-furyl)2-thiazolyl]formamide or N-butyl-N-[hy-
droxybutylnitrosamine, have been used to develop
animal models of experimental bladder carcinogene-
sis (3, 4, 39). Human exposures to these chemicals is
quite variable. Some of these chemicals are used
only in scientific laboratories and may provide po-
tential exposures only to the persons working with
them (3). With others, occupational, distributive, or
consumer exposures may be significant. In other
cases, as with the artificial sweeteners, cyclamate
and saccharin, commercial application, distribution,
or consumption involve the majority of individuals
in a given society (42). Such widespread usage cre-
ates much difficuly in the design of appropriate epi-
demiological studies in human populations. Both cy-
clamate and saccharin have evidenced bladder carci-
nogenicity for rats and mice exposed under a vari-
ety of circumstances (42). Additionally, they pro-
mote the action of known vesical carcinogens in the
bladders of both sexes of rats (39, 40, 42). Available
epidemiological data suggest that human exposure
to saccharin provides a small risk of bladder carci-
nogenesis in the general population, or a larger in-
creased risk in some persons with high exposures
or confounding exposures to other bladder carcino-
gens such as cigarettes or perhaps coffee (42). As
products containing artificial sweeteners are widely
consumed by people, and since only 20 years has oc-
curred since their generalized commercial introduc-
tion, it still seems prudent to recommend that cau-
tion be employed in the indiscriminate or long-term
use of these products, especially by children and
young adults.
Future Directions
Despite the progress that has been made in un-
derstanding the pathogenesis of human and experi-
mental bladder carcinogenesis, many opportunities
for future studies remain. The control of this and
other elusive neoplastic diseases can profitably be
approached by a dissection of pathogenic mecha-
nisms into their identifiable component processes.
Through such analyses a comprehensive process-ori-
entated understanding will enable us to devise
mechanisms of control. Advocacy of cessation of
smoking might be anticipated to substantially re-
duce bladder, pulmonary, and certain other neo-
plasms as major disease problems. Curtailment of
usage of certain occupational bladder carcinogens
must continue to be a part of public policy.
Refinements of methods for the identification of
bladder carcinogens and the investigation of their
complex interactions are required. A major difficul-
ty in human risk assessment is related to extrapola-
tion ofdata from animals to humans; improved meth-
ods of study are needed here. Dose-response rela-
tionships are incompletely understood in risk analy-
sis. Are there "threshold" doses for bladder carcino-
gens? Does the addition of other carcinogens or non-
carcinogens alter this? A substantial effort to edu-
cate practicing physicians and nonscientists to the
concepts of carcinogenesis and to the opportunities
to apply these concepts to the prevention of cancer
is required. Through these multiple approaches im-
plementation of preventative measures can be
sought for the betterment of all.
The studies cited as conducted in my laboratory were sup-
ported in part by Public Health Service Research Grants CA
11946, CA 14520, CA 14523, CA 14524, and CA 20432 from the
National Cancer Institute. Grants CA 14523 and CA 14524
were through the National Bladder Cancer Project. We thank
Mrs. S. Pertzborn for manuscript preparation and editorial as-
sistance.
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